bf/NASDAQ:ARWR_icon.jpeg

NASDAQ:ARWR

Arrowhead Pharmaceuticals, Inc.

  • Stock

USD

Last Close

24.13

03/05 20:00

Market Cap

3.52B

Beta: 1.01

Volume Today

614.56K

Avg: 1.11M

PE Ratio

−16.68

PFCF: −12.05

Sep '13
Sep '14
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
average inventory
644.96K
-
1.08M
67.24%
1.07M
1.03%
2.29M
114.78%
3.78M
65.05%
4.31M
13.79%
-8.63M
300.30%
-10.81M
25.28%
average payables
1.04M
-
1.89M
81.90%
3.81M
101.40%
8.63M
126.83%
8.15M
5.53%
3.44M
57.80%
5.23M
51.92%
7.24M
38.47%
8.14M
12.48%
6.16M
24.32%
19.37M
214.27%
average receivables
1.27M
-
41.83K
96.72%
37.50K
-
71.40K
90.40%
197.59K
176.74%
494.37K
150.20%
753.52K
52.42%
5.55M
636.59%
5.83M
5.08%
705K
87.91%
book value per share
1.15
-
3.55
209.73%
1.92
45.87%
1.57
18.50%
1.10
29.62%
1.15
3.95%
2.61
127.52%
4.58
75.93%
3.94
14.05%
1.01
74.49%
2.54
152.90%
capex per share
-0.01
-
-0.04
195.84%
-0.03
6.11%
-0.06
84.04%
-0.11
69.46%
-0.02
84.14%
-0.13
652.46%
-0.12
7.20%
-0.23
91.44%
-0.50
120.37%
-1.66
230.72%
capex to depreciation
-0.17
-
-1.28
652.90%
-0.84
33.91%
-1.18
40.38%
-1.69
42.57%
-0.30
82.08%
-2.70
793.89%
-2.01
25.60%
-2.85
41.74%
-5.06
77.66%
-14.15
179.34%
capex to operating cash flow
0.02
-
0.05
210.88%
0.03
38.15%
0.06
99.78%
0.33
452.05%
0.03
90.90%
-0.07
330.45%
0.13
280.65%
-0.14
209.85%
0.39
381.67%
1.15
196.23%
capex to revenue
-1.02
-
-9.81
859.49%
-5.16
47.43%
-24.38
372.61%
-0.25
98.97%
-0.09
65.08%
-0.07
19.25%
-0.14
91.04%
-0.17
25.47%
-0.22
27.32%
-0.73
238.35%
cash per share
1.17
-
3.28
180.13%
1.72
47.59%
1.40
18.78%
0.89
36.51%
0.92
3.07%
2.76
201.22%
3.13
13.64%
3.55
13.18%
3.57
0.71%
3.78
5.90%
days of inventory on hand
days payables outstanding
days sales outstanding
105.20
-
172.90
-
0.79
99.54%
7.40
839.52%
1.43
80.68%
3.51
145.29%
27.07
671.61%
2.12
92.18%
debt to assets
0.06
-
0.01
90.94%
0.01
2.53%
0.02
271.18%
0.02
14.45%
0.02
14.47%
0.03
59.64%
0.04
21.65%
0.04
11.08%
0.12
227.75%
0.15
27.61%
debt to equity
0.08
-
0.01
92.67%
0.01
12.12%
0.03
314.64%
0.03
9.03%
0.02
22.00%
0.05
95.99%
0.05
3.77%
0.06
36.50%
0.77
1,132.11%
0.42
44.87%
dividend yield
earnings yield
-0.23
-
-0.08
62.91%
-0.28
229.02%
-0.18
34.56%
-0.11
41.00%
-0.03
68.46%
0.03
175.83%
-0.02
175.86%
-0.02
11.55%
-0.05
132.93%
-0.07
41.28%
enterprise value
119.76M
-
561.71M
369.02%
249.93M
55.51%
366.09M
46.48%
297.68M
18.69%
1.58B
430.40%
2.42B
53.47%
4.21B
73.93%
6.32B
49.90%
3.46B
45.27%
2.87B
16.92%
enterprise value over ebitda
-8.07
-
-13.54
67.80%
-2.59
80.87%
-4.94
90.86%
-8.97
81.46%
-30.56
240.77%
36.92
220.83%
-48.32
230.88%
-44.88
7.12%
-19.37
56.84%
-15.27
21.19%
ev to operating cash flow
-6.29
-
-15.86
152.06%
-3.80
76.02%
-5.68
49.39%
-12.43
118.84%
-33.43
168.88%
14.00
141.88%
-44.18
415.50%
36.90
183.51%
-25.40
168.84%
-18.67
26.51%
ev to sales
412.59
-
3.21K
677.95%
654.26
79.62%
2.31K
253.39%
9.48
99.59%
97.81
932.00%
14.36
85.32%
47.90
233.66%
45.69
4.62%
14.22
68.88%
11.93
16.06%
free cash flow per share
-0.81
-
-0.79
1.76%
-1.18
49.13%
-1.12
5.20%
-0.43
61.46%
-0.58
34.91%
1.72
394.99%
-1.07
162.12%
1.42
233.55%
-1.79
225.90%
-3.10
72.85%
free cash flow yield
-0.14
-
-0.05
62.15%
-0.20
282.40%
-0.15
25.71%
-0.10
34.58%
-0.03
69.59%
0.06
301.09%
-0.02
140.65%
0.02
192.11%
-0.05
337.81%
-0.12
112.60%
graham net net
0.69
-
2.93
322.77%
1.33
54.65%
0.87
34.68%
0.58
32.96%
0.73
25.61%
1.65
126.34%
2.56
54.78%
0.74
71.22%
-2.08
382.75%
-0.70
66.34%
graham number
5.78
-
9.99
72.69%
8.32
16.66%
6.87
17.50%
3.40
50.54%
4.10
20.61%
6.52
59.09%
9.31
42.80%
10.97
17.90%
6.15
43.92%
10.49
70.44%
income quality
0.61
-
0.60
1.16%
0.71
18.31%
0.79
10.31%
0.70
11.68%
0.87
24.55%
2.55
193.51%
1.13
55.68%
-1.22
207.75%
0.77
163.45%
0.74
4.66%
intangibles to total assets
0.09
-
0.01
93.61%
0.19
3,285.50%
0.17
7.86%
0.20
13.77%
0.17
14.54%
0.05
70.99%
0.03
39.72%
0.02
34.57%
0.02
10.15%
0.01
22.46%
interest coverage
-0.08
-
-0.13
59.47%
-0.31
133.65%
-0.09
71.02%
-0.05
40.14%
0.01
116.49%
-0.01
215.26%
-24.35
240,145.38%
-35.47
45.64%
-11.19
68.46%
interest debt per share
0.10
-
13.78
14,250.48%
12.73
7.62%
4.40
65.44%
5.65
28.50%
12.56
122.30%
74.25
491.00%
91.46
23.17%
0.31
99.67%
0.82
169.16%
1.25
52.23%
inventory turnover
invested capital
0.08
-
0.01
92.67%
0.01
12.12%
0.03
314.64%
0.03
9.03%
0.02
22.00%
0.05
95.99%
0.05
3.77%
0.06
36.50%
0.77
1,132.11%
0.42
44.87%
market cap
136.57M
-
693.20M
407.57%
330.38M
52.34%
448.72M
35.82%
319.98M
28.69%
1.61B
402.12%
2.64B
64.62%
4.34B
63.98%
6.48B
49.34%
3.48B
46.20%
2.87B
17.68%
net current asset value
17.25M
-
137.97M
699.87%
80.22M
41.85%
57.35M
28.51%
44.75M
21.97%
62.40M
39.45%
159.44M
155.51%
261.65M
64.11%
83.27M
68.17%
-209.58M
351.69%
-367.50M
75.35%
net debt to ebitda
1.13
-
3.17
179.84%
0.83
73.70%
1.12
33.83%
0.67
39.77%
0.54
19.90%
-3.38
727.95%
1.40
141.54%
1.13
19.60%
0.15
86.88%
-0.02
115.36%
net income per share
-1.30
-
-1.25
3.72%
-1.60
28.31%
-1.34
16.49%
-0.47
65.24%
-0.65
39.93%
0.72
211.24%
-0.84
215.91%
-1.36
61.73%
-1.67
23.31%
-1.92
14.86%
operating cash flow per share
-0.79
-
-0.75
4.84%
-1.15
51.81%
-1.06
7.88%
-0.32
69.30%
-0.56
74.29%
1.84
426.52%
-0.95
151.37%
1.65
274.27%
-1.29
178.24%
-1.44
11.64%
payables turnover
receivables turnover
3.47
-
2.11
-
463.26
21,843.99%
49.31
89.36%
255.22
417.61%
104.05
59.23%
13.48
87.04%
172.50
1,179.25%
research and ddevelopement to revenue
29.99
-
132.22
340.84%
150.29
13.67%
261.82
74.21%
1.01
99.61%
3.28
225.21%
0.48
85.37%
1.46
205.03%
1.49
1.88%
1.22
18.08%
1.47
20.03%
return on tangible assets
-0.91
-
-0.32
64.70%
-0.86
165.34%
-0.77
9.91%
-0.41
46.63%
-0.59
42.53%
0.20
134.83%
-0.17
181.62%
-0.20
21.29%
-0.26
28.35%
-0.27
4.71%
revenue per share
0.01
-
0.00
69.17%
0.01
78.61%
0.00
61.06%
0.43
16,287.80%
0.19
54.59%
1.80
831.81%
0.87
51.42%
1.33
52.58%
2.31
73.08%
2.26
2.25%
roe
-1.13
-
-0.35
68.92%
-0.83
137.04%
-0.86
2.46%
-0.42
50.62%
-0.57
34.61%
0.28
148.89%
-0.18
165.89%
-0.34
88.16%
-1.67
383.47%
-0.76
54.58%
roic
-0.95
-
-0.32
66.59%
-0.86
171.80%
-0.83
3.23%
-0.44
47.00%
-0.57
29.36%
0.24
141.78%
-0.18
177.59%
-0.32
75.33%
-0.68
109.18%
-0.41
38.90%
sales general and administrative to revenue
40.28
-
139.54
246.40%
90.89
34.87%
258.94
184.91%
1.02
99.61%
1.18
16.11%
0.16
86.71%
0.59
277.62%
0.59
1.43%
0.51
12.64%
0.38
24.85%
shareholders equity per share
1.15
-
3.55
209.73%
1.92
45.87%
1.57
18.50%
1.10
29.62%
1.15
3.95%
2.61
127.52%
4.58
75.93%
3.94
14.05%
1.01
74.49%
2.54
152.90%
stock based compensation to revenue
5.29
-
32.55
515.00%
26.79
17.70%
73.24
173.40%
0.25
99.66%
0.52
108.45%
0.07
85.98%
0.49
571.50%
0.55
12.46%
0.50
10.36%
0.32
34.70%
tangible asset value
22.49M
-
164.97M
633.39%
84.80M
48.60%
72.86M
14.08%
60.40M
17.10%
76.48M
26.61%
226.97M
196.79%
446.42M
96.68%
395.16M
11.48%
94.00M
76.21%
276.90M
194.58%
tangible book value per share
0.94
-
3.52
275.07%
1.48
57.94%
1.19
19.28%
0.82
31.51%
0.91
11.87%
2.42
164.47%
4.43
83.28%
3.81
14.06%
0.89
76.59%
2.59
190.93%
working capital
20.12M
-
142.95M
610.55%
86.97M
39.16%
64.86M
25.42%
49.20M
24.14%
66.40M
34.96%
168.18M
153.26%
281.69M
67.50%
238.06M
15.49%
302.30M
26.98%
110.03M
63.60%

All numbers in USD (except ratios and percentages)